70 results
424B4
PPCB
Propanc Biopharma, Inc.
16 Oct 23
Prospectus supplement with pricing info
8:21pm
to purchase up to $5 million of shares of Common Stock over a 36-month term.
The Company paid a commitment fee to the Selling Stockholder for entering … ”) as a commitment fee upon the terms and subject to the limitations and conditions set forth in such First Warrant at an “Exercise Price” of $2,250,000
8-K
EX-4.1
PPCB
Propanc Biopharma, Inc.
21 Aug 23
Entry into a Material Definitive Agreement
5:25pm
such indebtedness) an aggregate maximum principal amount or commitment greater than Fifty Thousand Dollars ($50,000), or (B) any such indebtedness shall become
8-K
EX-10.1
nah7rl
26 Jul 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.2
r768mjrd00pbio6vm 4y
15 May 23
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-10.1
54lsdocw
15 May 23
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-10.3
g2amxrrs
15 May 23
Entry into a Material Definitive Agreement
4:06pm
424B3
nyd602
4 Apr 23
Prospectus supplement
11:22am
424B3
qv1ssgjg2spoige
22 Feb 22
Prospectus supplement
11:53am
POS AM
jtmgmvot3s
10 Jan 22
Prospectus update (post-effective amendment)
4:46pm
8-K
z7vlr9k4a8g
7 Dec 21
Entry into a Material Definitive Agreement
4:37pm
8-K
EX-10.2
6f4xyssxl4 k7ly
7 Dec 21
Entry into a Material Definitive Agreement
4:37pm